Elbit Med Tech
Elbit Medical Technologies Ltd, an investment holding company, engages in the research, development, production, and marketing of magnetic and focused imaging equipment in the United States, Europe, and internationally. The company is developing a magnetic resonance imaging guided focused ultrasound treatment equipment to address various oncology and gynecology indications, as well as neurologica… Read more
Elbit Med Tech (EMTC) - Net Assets
Latest net assets as of December 2022: ILA25.01 Million ILA
Based on the latest financial reports, Elbit Med Tech (EMTC) has net assets worth ILA25.01 Million ILA as of December 2022.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA25.53 Million) and total liabilities (ILA522.00K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ILA25.01 Million |
| % of Total Assets | 97.96% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | 261.9% |
| Growth Volatility | 606.31 |
Elbit Med Tech - Net Assets Trend (2008–2022)
This chart illustrates how Elbit Med Tech's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Elbit Med Tech (2008–2022)
The table below shows the annual net assets of Elbit Med Tech from 2008 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-12-31 | ILA25.01 Million | -18.09% |
| 2021-12-31 | ILA30.53 Million | -33.71% |
| 2020-12-31 | ILA46.06 Million | +225.55% |
| 2019-12-31 | ILA-36.69 Million | -136.78% |
| 2018-12-31 | ILA-15.49 Million | +63.44% |
| 2017-12-31 | ILA-42.38 Million | -33.98% |
| 2016-12-31 | ILA-31.64 Million | -136.42% |
| 2015-12-31 | ILA-13.38 Million | -1444.82% |
| 2014-12-31 | ILA995.00K | -85.60% |
| 2013-12-31 | ILA6.91 Million | +116.93% |
| 2011-12-31 | ILA-40.83 Million | -279.81% |
| 2010-12-31 | ILA-10.75 Million | +92.41% |
| 2009-12-31 | ILA-141.63 Million | -18.08% |
| 2008-12-31 | ILA-119.95 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Elbit Med Tech's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 11692700000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2022)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | ILA82.68 Million | 330.56% |
| Total Equity | ILA25.01 Million | 100.00% |
Elbit Med Tech Competitors by Market Cap
The table below lists competitors of Elbit Med Tech ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
3 Year Fixed Rate
KAR:P03FRR180927
|
$3.66K |
|
SAS Florentaise
F:QR0
|
$3.67K |
|
10 Year Fixed Rate
KAR:P10FRR211034
|
$3.67K |
|
Virgin Wines UK PLC
LSE:VINO
|
$3.67K |
|
Vitalist Inc.
V:VITA
|
$3.65K |
|
SMARTER WEB CO.PLC LS-001
F:3M8
|
$3.65K |
|
Nuvonyx Inc
PINK:TFGL
|
$3.65K |
|
eco5tech S.A.
WAR:ECT
|
$3.65K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Elbit Med Tech's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from 30,533,000 to 25,011,000, a change of -5,522,000 (-18.1%).
- Net loss of 5,111,000 reduced equity.
- Share repurchases of 411,000 reduced equity.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ILA-5.11 Million | -20.44% |
| Share Repurchases | ILA411.00K | -1.64% |
| Total Change | ILA- | -18.09% |
Book Value vs Market Value Analysis
This analysis compares Elbit Med Tech's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 80.52x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | ILA-0.18 | ILA22.20 | x |
| 2018-12-31 | ILA-0.07 | ILA22.20 | x |
| 2019-12-31 | ILA-0.16 | ILA22.20 | x |
| 2020-12-31 | ILA0.50 | ILA22.20 | x |
| 2021-12-31 | ILA0.36 | ILA22.20 | x |
| 2022-12-31 | ILA0.28 | ILA22.20 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Elbit Med Tech utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -20.44%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.02x
- Recent ROE (-20.44%) is above the historical average (-76.39%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | 0.00% | -482.15% | 0.38x | 0.00x | ILA-105.72 Million |
| 2009 | 0.00% | -154.17% | 0.83x | 0.00x | ILA-7.20 Million |
| 2013 | -170.08% | 0.00% | 0.00x | 5.89x | ILA-12.45 Million |
| 2014 | -942.51% | 0.00% | 0.00x | 33.73x | ILA-9.48 Million |
| 2015 | 0.00% | 0.00% | 0.00x | 0.00x | ILA-14.19 Million |
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | ILA-15.49 Million |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | ILA-6.51 Million |
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | ILA28.37 Million |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | ILA-17.55 Million |
| 2020 | 267.15% | 0.00% | 0.00x | 1.80x | ILA118.44 Million |
| 2021 | -50.83% | 0.00% | 0.00x | 1.02x | ILA-18.57 Million |
| 2022 | -20.44% | 0.00% | 0.00x | 1.02x | ILA-7.61 Million |
Industry Comparison
This section compares Elbit Med Tech's net assets metrics with peer companies in the Healthcare Equipment & Supplies industry.
No peer company data available for comparison.